Trials / Completed
CompletedNCT04050163
MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)
Safety and Preliminary Efficacy Study of Intravenous Administration of MiSaver® (Myocardial Infarction Saver) After Acute Myocardial Infarction, a Phase I/IIa Clinical Trial.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Honya Medical Inc · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the present study is to establish the safety and efficacy of MiSaver® Stem Cell Treatment After a Heart Attack (Acute Myocardial Infarction)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MiSaver® | Intravenous administration of MiSaver® Stem Cell via peripheral vein access. |
Timeline
- Start date
- 2021-01-26
- Primary completion
- 2023-05-04
- Completion
- 2023-05-04
- First posted
- 2019-08-08
- Last updated
- 2024-03-29
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04050163. Inclusion in this directory is not an endorsement.